W. Ascherman Professor and Chair of Department of Genetics and Director of the Center for Genomics and Personalized Medicine at Stanford University School of Medicine
Dr. Snyder is a leader in the field of systems biology encompassing genomics, proteomics, metabolomics as related to human health and disease. Most recently his laboratory has pioneered the use of wearable devices and omic analysis to monitor human physiology and to guide clinical interventions. Dr. Snyder has published more than 500 papers, and he has received numerous awards. He co-founded several biotechnology companies, including Protometrix (now part of Life Technologies), Affomix (now part of Illumina), Excelix, and Personalis (NASDAQ: PSNL).
Dr. Snyder is a founder and an inventor of Filtricine’s foundational patent from Stanford University School of Medicine.